VACCINE AND TREATMENT EVALUATION UNITS: PHASE I INFLUENZA VACCINE CLINICAL TRIAL

NIH RePORTER · NIH · N01 · $262,361 · view on reporter.nih.gov ↗

Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations is also available.

Key facts

NIH application ID: 10240244
Project number: 272201300022I-P00007-27200016-1
Recipient: UNIVERSITY OF MARYLAND BALTIMORE
Principal Investigator: KAREN KOTLOFF
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $262,361
Award type: —
Project period: 2016-09-16 → 2021-08-31